CA2486905A1 - Cosmetic compositions containing salts of malonic acid - Google Patents

Cosmetic compositions containing salts of malonic acid Download PDF

Info

Publication number
CA2486905A1
CA2486905A1 CA002486905A CA2486905A CA2486905A1 CA 2486905 A1 CA2486905 A1 CA 2486905A1 CA 002486905 A CA002486905 A CA 002486905A CA 2486905 A CA2486905 A CA 2486905A CA 2486905 A1 CA2486905 A1 CA 2486905A1
Authority
CA
Canada
Prior art keywords
weight
malonic acid
salt
cosmetic composition
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002486905A
Other languages
French (fr)
Inventor
Joseph Raymond Faryniarz
Philip Edward Miner
Michael Charles Cheney
Joanna Hong Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2486905A1 publication Critical patent/CA2486905A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12Face or body powders for grooming, adorning or absorbing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A cosmetic composition is provided which includes as an active material a salt of malonic acid in a cosmetically acceptable carrier, wherein the composition exhibits a Flexibility Value greater than 1 according to the Porcine Skin Test.

Description

COSMETIC COMPOSITIONS
CONTAINING SALTS OF MALONIC ACID
The invention concerns cosmetic compositions containing salts of malonic acid, and use of these compositions to control the signs of skin aging.
A soft, supple and flexible skin has a marked cosmetic appeal and is an attribute of normal functioning epidermis.
As human skin ages with advancing years, the epidermis can become folded, ridged or furrowed to form wrinkles. These signal loss of youthful appearance and herald the transition to old age. Exposure to excessive doses of sunlight accelerates the transition process. Also, the outer layer of the epidermis known as the stratum corneum can become dry and flaky following exposure to cold weather or excessive contact with detergents or solvents. Loss of skin moisture thereby results and the skin begins to lose the soft, supple and flexible characteristics.
Emollients such as fats, phospholipids and sterols have in the past been used to soften wrinkled or dry skin. These emollients are only partially effective as a remedy for skin in poor condition.
The use of hydroxy carboxylic acids for enhancing the quality of human skin has been known for some time. There is no doubt that alpha-hydroxy carboxylic acids are effective much beyond the common emollients.
- 2 -U.S. Patent 4,424,234 (Alderson et al.) discloses skin treatment compositions incorporating alpha-hydroxycaproic acid and alpha-hydroxycaprylic acid or mixtures thereof in compositions that have a pH value of less than 7, usually from 2 to 4. Yu and Van Scott have patented widely in this area. For instance, U.S. Patent 4,105,782 reports amines or ammonium salts of alpha-hydroxy carboxylic acids in the treatment of acne or dandruff. In U.S. Patent 4,105,783 and U.S. Patent 4,197,316, these compounds are suggested for the treatment of dry skin. U.S. Patent 4,234,599 discloses the use of alpha-hydroxy carboxylic acids, their esters or amine salts in the treatment of keratoses. More recently, U.S.
Patent 5,091,171 focused attention on these compounds as being effective against age spots, wrinkles and aging related skin changes.
Whilst hydroxy carboxylic acids hold much therapeutic promise, the materials have been found to irritate human skin on repeated topical applications. The irritation may range from a sensation of tingling, itching and burning to clinical signs of redness and peeling. Causes for such irritation have been linked to the lowering of pH in the stratum corneum of human skin. Low pH has been suggested as provoking disturbances in intercorneocyte bondings resulting in adverse skin reactions, especially in some individuals with sensitive skin.
Organic acids other than alpha-hydroxy functionalized have been disclosed in the cosmetic literature. For instance, U.S. Patent 5,641,495 (Jokura et al.) discloses in combination a ceramide or pseudoceramide, a dicarboxylic u: ~'.
-3-acid and a salt of a dicarboxylic acid. The Examples illustrate sodium and potassium salts of succinic acid. Lower molecular weight dicarboxylic acids such as malonic may also be utilized. Although excellent moisturization and little accompanying irritation occurs, there is no suggestion that this system combats signs of aging leading to loss of softness, suppleness, and flexibility of skin. Improvements in these areas remain as an unfulfilled need of the consumer.
Accordingly, it is an advantage of the present invention to provide new cosmetic ingredients in compositions which are effective at controlling and even eliminating the signs of aging, particularly with respect to improving skin softness, suppleness and flexibility.
Thus, according to a first aspect of the invention,, there is provided a cosmetic composition which includes:
(i) from 0.1% to 30% by weight of an ammonium, dimethylethanolammonium or tris(hydroxymethyl)methane ammonium salt of malonic acid, the malonic acid being present as a half neutralized and a fully neutralized acid in a molar ratio ranging from 2:1 to 1:200;
(ii) from about 1% to about 99.9% by weight of a cosmetically acceptable carrier;
wherein the composition exhibits a Flexibility Value greater than 1 inthe Porcine Skin Test.
Furthermore, there is provided a method for controlling signs of aging which includes:
providing a cosmetic composition including:
(i) from 0.1% to 30% by weight of a salt of malonie acid, the malonic acid being present as a half neutralized V fn ' ~~\ k ... E ~' and a fully neutralized acid in a molar ratio ranging from 2:1 to 1:200;
4 PCT/EP03/05477 (ii) from about 1% to about 99.9% by weight of a cosmetically acceptable carrier;
wherein the composition exhibits a Flexibility Value greater than 1 in the Porcine Skin Test; and applying the cosmetic composition to the skin.
We have now found that salts of malonic acid are at least as effective as alpha-hydroxy carboxylic acids in combating the signs of skin aging. Most particularly, salts of malonic acid have shown significant activity in improving the softness, suppleness and flexibility of skin.
A feature of the present invention is that malonate salts are those which impart to the composition a positive Flexibility Value of at least 1, preferably at least 1.1 relative to water in the Porcine Skin Test. This test utilizes a thermo-mechanical analyzer with a 20 gram load to a one-cm diameter disc of Porcine Skin from which the immediate deflection is recorded in mm. Water serves as a control. Skin samples are measured before and 24 hours after one, two and three treatments. These treatments consist of 150 ~,l of each composition being applied to the skin for five minutes, then removed without rinsing.
Thereafter, drying is performed at 21°C and less than 100 relative humidity.
Data transformation consists of determining the ratio of the deflection value after three applications of the test composition to the deflection value of the water standard.
The ratio is defined as the Flexibility Value.
- 5 -A wide variety of counter rations to the malonate anions may be utilized in forming the salt. Malonate salts may either be the half or fully neutralized malonic acid or combinations thereof, as represented by general formulas (I) and (II) [H02CCH~CO~] [X] + + [X] 2 [02CCH~C02]
I II
wherein X is a cationic counterion.
Suitable cationic counterions include those of alkali and alkaline earth metals. Representative examples include the rations of lithium, sodium, potassium, magnesium, calcium, ammonium and combinations thereof.
Not only inorganic but also organic rations can be employed.
Particularly useful are quaternized nitrogen rations having from 1 to 1,000, preferably from 1 to 20, and optimally from 3 to 12 carbon atoms. Illustrative are those rations derived from amines which include triethanolamine, diethanolamine, propanolamine, monoethanolamine, methylamine, ethylamine, propylamine, isopropylamine, butylamine, isobutylamine, t-butylamine, pentylamine, isopentylamine, hexylamine, cyclohexylamine, cyclopentylamine, norbornylamine, octylamine, ethylhexylamine, nonylamine, decylamine, pyrrolidone, amino acids (lysine, arginine, alanine, glutamine, histidine, glycine), 2-amino-2-methyl-1-propanol, dimethylethanolamine, polyethyleneimine, tris(hydroxymethyl)amino methane and combinations thereof.

a, 7 CA 02486905 2004-11-22 ~~~'~~~"HG~.,~ ~°;'
-6-Most prefexxed are the cations derived from ammonia, dimethylethanolamine and tris(hydroxymethyl)amino~methane.
Typical malonate salts derived from these preferred materials include ammonium malonate, diammonium malonate, dimethylethanolammonium malonate, bis (dimethylethanolammonium) malonate, tris(hydroxymethyl)methane ammonium malonate, and di [tris (hydroxymethyl ) methane ammonium] malonate .
Amounts of the malonic acid salt may range from about 0.1% to about 30%, preferably from about 0.1% to about 15%, more preferably from about 0.5% to about 10%, optimally from about I% to about 8% by weight of the cosmetic composition.
The present invention utilizes as the active ingredient mixtures of salt I and salt II. The molar ratio of mono-salt I
to di-salt II may range from about 2:1 to about 1:200, optimal3y from about 1:1 to about 1:20.
Compositions of this invention will also include a cosmetically acceptable carrier. Amounts of the carrier may range from 1%
to 99.9%, preferably from about 70% to about 95%, optimally from about 80% to about 90%. Among the useful carriers are water, emollients, fatty acids, fatty alcohols, humectants, thickeners and combinations thereof. The carrier may be aqueous, anhydrous or an emulsion. Preferably the compositions are aqueous, especially water and oil emulsions of the W/O or O/W or triplex W/O/W

_ 7 _ variety. Water when present may be in amounts ranging from about 5% to about 950, preferably from about 20% to about 70%, optimally from about 35o to about 60% by weight.
Emollient materials may serve as cosmetically acceptable carriers. These may be in the form of silicone oils, synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from about 0.1% to about 95o, preferably between about 1% and about 50% by weight.
Silicone oils may be divided into the volatile and nonvolatile variety. The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms.
Non-volatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially non-volatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 x 10 to 0.1 m2/s at 25°C. Among the preferred non-volatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from about 1 x 10 to about 4 x 10 4 m2/s at 25°C.
Another class of non-volatile silicones are emulsifying and non-emulsifying silicone elastomers. Representative of this _ g _ category is Dimethicone/Vinyl Dimethicone Crosspolymer available as Dow Corning 9040, General Electric SFE 839, and Shin-Etsu KSG-18. Silicone waxes such as Silwax WS-L
(Dimethicone Copolyol Laurate) may also be useful.
Among the ester emollients are:
(1) Alkenyl or alkyl esters of fatty acidshaving 10 to 20 carbon atoms. Examples thereof include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate, oleyl stearate, and oleyl oleate.
(2) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
(3) Polyhydric alcohol esters. Ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters. Particularly useful are _ g _ pentaerythritol, trimethylolpropane and neopentyl glycol esters of C1-C3p alcohols.
(4) Wax esters such as beeswax, spermaceti wax and tribehenin wax.
(5) Sterols esters, of which cholesterol fatty acid esters are examples thereof.
(6) Sugar ester of fatty acids such as sucrose polybehenate and sucrose polycottonseedate.
Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C11-C13 isoparaffins, polyalphaolefins, and especially isohexadecane, available commercially as Permethyl 101A from Presperse Inc.
Fatty acids having from 10 to 30 carbon atoms may also be suitable as cosmetically acceptable carriers. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachidic, behenic and erucic acids.
Fatty alcohols having from 10 to 30 carbon atoms are another useful category of cosmetically acceptable carrier.
Illustrative of this category are stearyl alcohol, lauryl alcohol, myristyl alcohol and cetyl alcohol.
Humectants of the polyhydric alcohol-type can be employed as cosmetically acceptable carriers. Typical polyhydric alcohols include glycerol, polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. The amount of humectant may range anywhere from 0.5o to 50%, preferably between 1% and 15% by weight of the composition.
Thickeners can be utilized as part of the cosmetically acceptable carrier of compositions according to the present invention. Typical thickeners include crosslinked acrylates (e. g. Carbopol 982~), hydrophobically-modified acrylates (e. g. Carbopol 1382~), cellulosic derivatives and natural gums. Among useful cellulosic derivatives are sodium carboxymethylcellulose, hydroxypropyl methocellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenan, pectin and combinations of these gums.
Inorganics may also be utilized as thickeners, particularly clays such as bentonites and hectorites, fumed silicas, and silicates such as magnesium aluminum silicate (Veegum~).
Amounts of the thickener may range from 0.0001% to 100, usually from 0.001% to lo, optimally from O.Olo to 0.5% by weight.

Cosmetic compositions of the present invention may be in any form. These forms may include lotions, creams, roll-on formulations, sticks, mousses, aerosol and non-aerosol sprays and fabric (e. g. nonwoven textile)-applied formulations.
Surfactants may also be present in cosmetic compositions of the present invention. Total concentration of the surfactant when present may range from about 0.1o to about 40~, preferably from about 1% to about 20%, optimally from about 1% to about 5% by weight of the composition. The surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteriC actives.
Particularly preferred nonionic surfactants are those with a C1p-C2p fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-C1p alkyl phenols condensed with from 2 to moles of alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di- Cg-C2p fatty acids; and polyoxyethylene 20 sorbitan as well as combinations thereof. Alkyl polyglyCOSides and saccharide fatty amides (e. g. methyl gluCOnamides) are also suitable nonionic surfactants.
Preferred anionic surfactants include soap, alkyl ether sulfates and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuCCinates, Cg-C2p aryl isethionate, Cg-C2p alkyl ether phosphates, Cg-Cep sarcosinates and combinations thereof.

Sunscreen actives may also be included in compositions of the present invention. Particularly preferred are such materials as ethylhexyl p-methoxycinnamate, available as Parsol MCX~, Avobenzene, available as Parsol 1789~ and benzophenone-3, also known as Oxybenzone. Inorganic sunscreen actives may be employed such as microfine titanium dioxide, zinc oxide, polyethylene and various other polymers. Amounts of the sunscreen agents when present may generally range from 0.1% to 300, preferably from 2% to 200, optimally from 4% to 10o by weight.
Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms. Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability.
Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the emulsion. Preservatives are preferably employed in amounts ranging from 0.01% to 2% by weight of the composition.

Compositions of the present invention may include vitamins.
Illustrative vitamins are Vitamin A (retinol), Vitamin B2, Vitamin B6, Vitamin C, Vitamin E and Biotin. Derivatives of the vitamins may also be employed. For instance, Vitamin C
derivatives include ascorbyl tetraisopalmitate, magnesium ascorbyl phosphate and ascorbyl glycoside. Derivatives of Vitamin E include tocopheryl acetate, tocopheryl palmitate and tocopheryl linoleate. DL-panthenol and derivatives may also be employed. Total amount of vitamins when present in compositions according to the present invention may range from 0.0010 to 10%, preferably from 0.01% to 10, optimally from 0.10 to 0.50 by weight.
Another type of useful substance can be that of an enzyme such as oxidases, proteases, lipases and combinations.
Particularly preferred is superoxide dismutase, commercially available as Biocell SOD from the Brooks Company, USA.
Skin lightening compounds may be included in the compositions of the invention. Illustrative substances are placental extract, lactic acid, niacinamide, arbutin, kojic acid, ferulic acid, resorcinol and derivatives including 4-substituted resorcinols and combinations thereof. Amounts of these agents may range from about 0.1% to about 10%, preferably from about 0.5% to about 2% by weight of the compositions.
Desquamation promoters may be present. Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids. The term "acid" is meant to include not only the free acid but also salts and C1-C3p alkyl or aryl esters thereof and lactones generated from removal of water to form cyclic or linear lactone structures. Representative acids are glycolic, lactic and malic acids. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from about 0.010 to about 15% by weight of the composition.
A variety of herbal extracts may optionally be included in compositions of this invention. Illustrative are green tea, chamomile, licorice and extract combinations thereof. The extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents.
Also included may be such materials as lipoic acid, retinoxytrimethylsilane (available from Clariant Corp. under the Silcare 1M-75 trademark), dehydroepiandrosterone (DHEA) and combinations thereof. Ceramides (including Ceramide 1, Ceramide 3, Ceramide 3B and Ceramide 6) as well as pseudoceramides may also be utilized for many compositions of the present invention may also be excluded. Amounts of these materials may range from about 0.0000010 to about 100, preferably from about 0.0001% to about 1o by weight.
Colorants, fragrances, opacifiers and abrasives may also be included in compositions of the present invention. Each of these substances may range from about 0.05% to about 50, preferably between 0.1% and 3% by weight.

The term "comprising" is meant not to be limiting to any subsequently stated elements but rather to encompass non-specified elements of major or minor functional importance.
In other words the listed steps, elements or options need not be exhaustive. Whenever the words "including" or "having" are used, these terms are meant to be equivalent to "comprising" as defined above.
EXAMPLES
Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word "about".
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated.
Example 1 A typical cosmetic cream according to the present invention is outlined under Table I.

TABLE I
INGREDIENT WEIGHT

PHASE
A

Water Balance Disodium EDTA 0.05 Meth I Paraben 0.15 Ma nesium Aluminum Silicate 0.60 Triethanolamine 1.20 PHASE
B

Xanthan Gum 0.20 Natrosol~ 250HHR eth I 0.50 cellulose But lene GI col 3.00 GI cerin 2.00 PHASE
C

Sodium Stearo I Lact late 0.10 GI cerol Monostearate 1.50 Stea I Alcohol 1.50 Isostea I Palmitate 3.00 Silicone Fluid 1.00 Cholesterol 0.25 Sorbitan Stearate 1.00 But lated H dro Toluene 0.05 Vitamin E Acetate 0.01 PEG-100 Stearate 2.00 Stearic Acid 3.00 Pro I Paraben 0.10 Parsol MCX~ 2.00 Ca lic/Ca ric Tri I ceride 0.50 H dro ca lic Acid 0.01 C12-15 Alk I Octanoate 3.00 PHASE
D

Malonate Salt 3.00 PHASE
E

Vitamin A Palmitate 0.10 Bisabolol 0.01 Vitamin A Acetate 0.01 Fra rance 0.03 Retinol 50C 0.02 Example 2 A water-in-oil topical liquid make-up foundation utilizing the malonate salts of the present invention is described in Table II below.
TABLE II
INGREDIENT WEIGHT

PHASE
A

C clomethicone 9.25 Cet I Octanoate 2.00 Dimethicone Co of of 20.00 PHASE
B

Talc 3.38 Pi ment Iron Oxides 10.51 S heron L-1500 Silica 0.50 PHASE
C

S nthetic Wax Durachem 0.10 Arachid I Behenate 0.30 PHASE
D

C clomethicone 1.00 Trih drox stearin ~ 0.30 PHASE
E

Laureth-7 0.50 Pro I Paraben 0.25 PHASE
F

Fra rance 0.05 PHASE
G

Water balance Ammonium Malonate 3.00 Meth I Paraben 0.12 Pro lens GI col 8.00 Niacinamide 4.00 GI cerin 3.00 Sodium Chloride 2.00 Sodium Deh droacetate 0.30 Example 3 Illustrated herein is a skin cream incorporating the malonate salts of the present invention.
TABLE III
INGREDIENT WEIGHT

GI cerin 6.93 Niacinamide 5.00 Dimeth lethanolammonium Malonate5.00 Permeth I 101 A 3.00 Se i e1305 2.50 Q2-1403 2.00 Iso ro I Isostearate 1.33 Arlatone 2121 1.00 Cet I Alcohol CO-1695 0.72 SEFA Cottonate 0.67 Toco herol Acetate 0.50 Panthenol 0.50 Stea I Alcohol 0.48 Titanium Dioxide 0.40 Disodium EDTA 0.10 GI dant Plus 0.10 PEG-100 Stearate 0.10 Stearic Acid 0.10 Purified Water Balance 1 Isohexadecane, Presperse Inc., South Plainfield, NJ

Polyacrylamide(and)C13-14 Isoparaffin(and) Laureth-7, l0 Seppic Corporation, Fairfield, NJ
3 dimethicone(and)dimethiconol, Dow Corning Corp. Midland, MI
4 Sorbitan Monostearate and Sucrococoate, ICI Americas Inc., Wilmington, DE
5 Sucrose ester of fatty acid CA 02486905 2004-11-22 '~a ~'. '~
u' o c ' S
6 DMDM Hydantoin (and) Iodopropynyl Butylcarbamate, Lonza Inc., Fairlawn, NJ
Example 4 Illustrative of a powdered cosmetic composition according to the present invention is the formula of Table IV.
TABLE IV
INGREDIENT WEIGHT

Pol silicone-11 27.5 C clomethicone 54 Petrolatum 11 Tris h dro meth I methaneammonium Malonate 7 Dimethicone Co of of 0.5 Example 6 An aerosol packaged foaming cleanser suitable for the present invention is outlined in Table VI.
TABLE VI
INGREDIENT WEIGHT

Sunflower Seed Oil 20.00 Maleated So bean Oil 5.00 Silicone Urethane 1.00 Pol I cero-4 Oleate 1.00 Sodium C14-16 Olefin Sulfonate 15.00 Sodium Lau I Ether Sul hate 25% 15.00 active Cocoamido ro Ibetaine 15.00 DC 1754~ Silicone Emulsion 50% 5.00 Pol uaternium-11 1.00 Malonate 1.00 monium Bis dimeth lethanolam _ ~ Balance _ Water An aerosol is prepared using 92% by weight of the concentrate in Table VI~and 8o propellant, the latter being a combination of dimethylether, isobutane and propane.
Example 7 An adhesive cosmetic patch may also be formulated according to the present invention. An adhesive hydrogel is prepared by mixing 30 grams of 2-aCrylamido-2-methylpropane sulphonic acid monomer in 20 grams distilled water and 5 grams of a 1%
aqueous solution of methylene-bis-acrylamide. The solution is then activated with. 0.4% magnesium persulphate catalyst.
Shortly after mixing the catalyst with the hydrogel solution, 0.1 grams ammonium malonate in 5 ml water is added. The resultant solution is coated onto a 50/50 blend of polypropylene and hydrophilic polyester and allowed to solidify. The resulting deposited hydrogel is warmed for 24 hours at 40°C in a hot air oven. Final water content of the hydrogel is 50%. A polystyrene backing layer is laid over the adhesive hydrogel.
Example 9 A variety of carboxylic acid salts were evaluated to determine their response in a Porcine Skin Test. A Perkin-Elmer Thermo-Mechanical Analyzer, Model TMS-1, was operated with a 20 gram load placed to a center of a one-cm diameter disc of Porcine Skin. Deflection of the skin in mm was immediately recorded.
The sample size was six pieces of skin per treatment. Water was used as a control. Each piece served as an internal control. Each was measured dry before and 24 hours after one, two and three treatments.
Each treatment consisted of 150,1 of a test material solution applied to skin for 5 minutes, then removed without rinsing. Drying conditions were 21°C and less then 100 humidity. Results are recorded in Table VIII.
TABLE VIII
Material Evaluated Flexibilit Value Water reference standard 1.00 Succinate Salt* 0.85 GI colate Salt* 0.85 Malonate Salt** ~ 1.36 * ammonium salt ** dimethylethanolammonium salt Evident from the results is that the malonate salt rendered the skin significantly more flexible. By contrast, the succinate and glycolate salts rendered the skin significantly stiffer. The effects of glycolate and succinate were statistically similar. These results indicate that malonate salts and compositions containing these salts can improve the softness, suppleness and flexibility.
Table IX records Flexibility Values as measured on the cosmetic cream formulation detailed under Table I (utilizing different Phase D actives). Flexibility Value for the malonate salt formulated cream was higher than either the base cream or a glycolate salt formulated cream. The results demonstrate that a softer, suppler and more flexible skin is achieved by use of malonates.
TABLE IX
Material Evaluated* Fllexibilit Value Water preference standard 1.00 Base Cream No Salt O,gg Base Cream GI colate Salt 0.84 Base Cream Malonate Salt 1.12 * Salt in parenthesis refers to Phase D active of Example 1 (Table I ) The foregoing description and examples illustrate selected embodiments of the present invention. In light thereof variations and modifications will be suggested to one skilled in the art, all of which are within the spirit and purview of this invention.

Claims (7)

1. A cosmetic composition comprising:
(i) from 0.1% to 30% by weight of an ammonium, dimethylethanolammonium or tris(hydroxymethyl)methane ammonium salt of malonic acid, the malonic acid being present as a half neutralized and a fully neutralized acid in a molar ratio ranging from 2:1 to 1:200;
(ii) from about 1% to about 99.9% by weight of a cosmetically acceptable carrier;
wherein the composition exhibits a Flexibility Value greater than 1 in the Porcine Skin Test.
2. A cosmetic patch or a towelette product containing a cosmetic composition according to claim 1.
3. A method for controlling signs of aging related to softness, suppleness and flexibility comprising:
providing a cosmetic composition comprising:
(i) from 0.1% to 30% by weight of a salt of malonic acid, the malonic acid being present as a half neutralized and a fully neutralized acid in a molar ratio ranging from 2:1 to 1:200;
(ii) from about 1% to about 99.9% by weight of a cosmetically acceptable carrier;
wherein the composition exhibits a Flexibility Value greater than 1 in the Porcine Skin Test; and applying the cosmetic composition to the skin.
4. The method according to claim 3 wherein the salt of malonic acid is an ammonium, dimethylethanolammonium or tris(hydroxymethyl)methane ammonium salt.
pentylamine, isopentylamine, hexylamine, cyclohexylamine, cyclopentylamine, norbornylamine, octylamine, ethylhexylamine, nonylamine, decylamine, pyrrolidone, amino acids (lysine, arginine, alanine, glutamine, histidine, glycine), 2-amino-2-methyl-1-propanol, dimethylethanolamine, tris(hydroxymethyl)amino methane and combinations thereof.
6. A cosmetic patch or a towlette product containing a cosmetic composition according to any of claims 1 to 5.
7. A method for controlling signs of aging comprising:
providing a cosmetic composition comprising:
(i) from about 0.0001% to about 30% by weight of a salt of malonic acid;
(ii) from about 1% to about 99.9% by weight of a cosmetically acceptable carrier;
wherein the composition exhibits a Flexibility Value greater than 1 in the Porcine Skin Test; and applying the cosmetic composition to the skin.
7. The method according to claim 6 wherein the signs of aging that are controlled are softness, suppleness and flexibility.
CA002486905A 2002-05-29 2003-05-22 Cosmetic compositions containing salts of malonic acid Abandoned CA2486905A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38383702P 2002-05-29 2002-05-29
US60/383,837 2002-05-29
US45533003P 2003-03-17 2003-03-17
US60/455,330 2003-03-17
PCT/EP2003/005477 WO2003099254A1 (en) 2002-05-29 2003-05-22 Cosmetic compositions containing salts of malonic acid

Publications (1)

Publication Number Publication Date
CA2486905A1 true CA2486905A1 (en) 2003-12-04

Family

ID=29587035

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002486905A Abandoned CA2486905A1 (en) 2002-05-29 2003-05-22 Cosmetic compositions containing salts of malonic acid

Country Status (10)

Country Link
EP (1) EP1509197A1 (en)
JP (1) JP2005531568A (en)
KR (1) KR20050007562A (en)
CN (1) CN1665479A (en)
AR (1) AR039908A1 (en)
AU (1) AU2003240709B2 (en)
CA (1) CA2486905A1 (en)
MX (1) MXPA04011904A (en)
TW (1) TW200404573A (en)
WO (1) WO2003099254A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202689A1 (en) * 2003-03-17 2004-10-14 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Terpenoid fragrance components stabilized with malonic acid salts
JP2006241021A (en) * 2005-03-01 2006-09-14 National Food Research Institute Antiallergic agent
WO2007089267A1 (en) * 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
JPS60185710A (en) * 1984-03-05 1985-09-21 Kao Corp Bath preparation of weak acidity
US5218001A (en) * 1984-03-19 1993-06-08 The Rockefeller University Inhibitors of the advanced glycosylation of proteins and methods of use therefor
DE4321753A1 (en) * 1993-06-30 1995-01-12 Beiersdorf Ag Deodorant cosmetics containing alpha,omega-alkanedicarboxylic acids
JP3299054B2 (en) * 1994-10-19 2002-07-08 花王株式会社 Skin cosmetics
JPH08268828A (en) * 1995-03-31 1996-10-15 Shiseido Co Ltd Pack cosmetic
AU6725496A (en) * 1995-08-15 1997-03-19 Robert Eric Montgomery Peroxidase-activating oral compositions
ES2199349T3 (en) * 1996-03-14 2004-02-16 Schering-Plough Healthcare Products, Inc. COMPOSITION AND METHOD TO BRONZE WITHOUT SUN.
JPH10175844A (en) * 1996-10-18 1998-06-30 Shiseido Co Ltd Degradation promoter of desmosome
EP0969089A1 (en) * 1998-06-29 2000-01-05 F. Hoffmann-La Roche Ag Phytase formulation
US6482423B1 (en) * 1999-04-13 2002-11-19 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram positive bacteria
US20020061282A1 (en) * 2000-10-11 2002-05-23 Constantine Georgiades Tooth whitening composition and method employing dicarboxylic acid whitening agent

Also Published As

Publication number Publication date
AU2003240709B2 (en) 2006-03-02
EP1509197A1 (en) 2005-03-02
TW200404573A (en) 2004-04-01
AR039908A1 (en) 2005-03-09
JP2005531568A (en) 2005-10-20
MXPA04011904A (en) 2005-03-31
KR20050007562A (en) 2005-01-19
CN1665479A (en) 2005-09-07
WO2003099254A1 (en) 2003-12-04
AU2003240709A1 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
EP1809235B1 (en) Method for moisutrizing the skin with dihydroxypropyltri (c1-c3 alkyl) ammonium salts
EP1804762B1 (en) Personal care compositions with salts of dihydroxypropyltri(c1-c3alkyl) ammonium monosubsituted polyols
US7404949B2 (en) Methods and compositions useful to prevent in-grown hair arising from shaving
EP1507510B1 (en) Cosmetic compositions with ammonium malonates
AU2003232824B2 (en) Cosmetic compositions with hydroxy amine salts of malonic acid
AU2003240709B2 (en) Cosmetic compositions containing salts of malonic acid
US20040185074A1 (en) Odor control in amine salt containing cosmetic compositions
AU2003240710B9 (en) Odor control in amine salt containing cosmetic compositions
US20040185073A1 (en) Cosmetic compositions containing salts of malonic acid
AU2004222662B2 (en) Compositions useful to prevent in-grown hair arising from shaving
Harichian et al. Method for moisturizing human skin using dihydroxypropyltri (C 1-C 3 alkyl) ammonium salts
KR20050016447A (en) Cosmetic compositions with ammonium malonates

Legal Events

Date Code Title Description
FZDE Discontinued